Annual Drug Patent Expirations for EPRONTIA
Eprontia is a drug marketed by Azurity and is included in a single NDA. It’s accessible from one provider.
The generic ingredient in EPRONTIA is topiramate. One provider is listed for this compound. Further particulars can be found on the topiramate profile web page.
For extra data on how DrugPatentWatch may also help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Choices with DrugPatentWatch
Copyright © DrugPatentWatch. Initially revealed at New patent for Azurity drug EPRONTIA